09.01.2019 • News

McDermott Wins Indian Polymer Contracts

McDermott Wins Indian Polymer Contracts
McDermott Wins Indian Polymer Contracts

US engineering contractor McDermott International has won technology contracts for three PP projects in India. A timescale and proposed start-up dates for the plants were not disclosed for any of the projects.

The first award was from HPCL Rajasthan Refinery Ltd. (HRRL) for the license and basic engineering design of two 490,000 t/y plants in Pachpadra Tehsil, Barmer district, Rajasthan. Both plants will use Lummus’s proprietary Novolen process reactors and proprietary NHP catalyst to produce a wide range of PP products for Indian and regional markets.

Daniel McCarthy, executive vice president of McDermott’s Lummus Technology business, said the project is the largest Novolen-licensed PP award to date and the largest PP plant in India. He commented: “Our process includes a high degree of flexibility to adjust to market demand and HRRL will enjoy the full benefits of economies of scale and technology capability for this world-scale plant.”

The other contract was awarded by Indian Oil for the license and basic engineering design of a 200,000 t/y plant in Barauni as well as a 420,000 t/y plant in Gujarat. Here, too, the plants will be based on Lummus’s Novolen process and NHP catalyst.

“By licensing this technology to enhance the profitability of both the Barauni refinery and the Gujarat Refinery, Indian Oil will be able to produce a variety of polypropylene products to meet India’s increasing demand for plastics,” McCarthy said.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.